These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17639669)

  • 1. [The role of radiotherapy in the management of prostate cancer].
    Bernier J
    Rev Med Suisse; 2007 Jun; 3(114):1472-4. PubMed ID: 17639669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormonal therapy associated with radiotherapy of advanced carcinoma of the prostate. Comment on the study and interview with Michel Bolla].
    Valdagni R; Zelefsky MJ
    Recenti Prog Med; 2001 Feb; 92(2):130-2. PubMed ID: 11294105
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of prostate cancer with goserelin and radiotherapy.
    Schoen SS
    N Engl J Med; 1997 Dec; 337(23):1693; author reply 1694. PubMed ID: 9411235
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating prostate cancer: another step forward.
    Harv Mens Health Watch; 1998 May; 2(10):7. PubMed ID: 9577263
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiotherapy in prostate cancer: data from ASTRO 2008].
    Coquard R
    Prog Urol; 2009 May; 19(5):297-300. PubMed ID: 19393533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla].
    Bolla M
    Recenti Prog Med; 2001 Feb; 92(2):128-9. PubMed ID: 11294104
    [No Abstract]   [Full Text] [Related]  

  • 7. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
    Palma D; Pickles T
    Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale.
    Febles C; Valicenti RK
    Urology; 2004 Nov; 64(5):855-61. PubMed ID: 15533463
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone treatment plus radiation delays growth of prostate cancer.
    Tanne JH
    BMJ; 2008 Jan; 336(7635):66. PubMed ID: 18187718
    [No Abstract]   [Full Text] [Related]  

  • 10. Current management of hormone-refractory prostate cancer.
    Scher HI
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):724-6. PubMed ID: 16163259
    [No Abstract]   [Full Text] [Related]  

  • 11. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of prostate cancer with hormonal therapy in Europe.
    Miller K; Anderson J; Abrahamsson PA
    BJU Int; 2009 Mar; 103 Suppl 2():2-6. PubMed ID: 19228146
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?
    Kollmeier MA; Zelefsky MJ
    Nat Clin Pract Urol; 2008 Nov; 5(11):584-5. PubMed ID: 18813218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
    Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
    Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The developing role of hormonal therapy in the treatment of prostate cancer.
    Abrahamsson PA
    BJU Int; 2009 Mar; 103 Suppl 2():1. PubMed ID: 19228145
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapy for prostate cancer.
    Elconin JH
    N Engl J Med; 2007 Jan; 356(3):309-10; author reply 310-1. PubMed ID: 17240536
    [No Abstract]   [Full Text] [Related]  

  • 17. Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials.
    Bria E; Cuppone F; Giannarelli D; Milella M; Ruggeri EM; Sperduti I; Pinnarò P; Terzoli E; Cognetti F; Carlini P
    Cancer; 2009 Aug; 115(15):3446-56. PubMed ID: 19484790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
    D'Amico AV; Renshaw AA; Loffredo B; Chen MH
    Cancer; 2007 Oct; 110(8):1723-8. PubMed ID: 17828774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of the hormone sensitivity of prostate cancer: where are we now?
    Alcaraz A
    Eur Urol; 2008 Aug; 54(2):247-50; discussion 250-1. PubMed ID: 18343562
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing prostate cancer: the role of hormone therapy.
    Ramirez ML; Keane TE; Evans CP
    Can J Urol; 2007 Dec; 14 Suppl 1():10-8. PubMed ID: 18163939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.